Don't want ads? Subscribe or login now.

Navinta Infringed Abraxis' Naropin Patents: Judge

By Jocelyn Allison · August 4, 2009, 5:43 PM EDT

Generic-drug manufacturer Navinta LLC has been found liable for infringing three patents for Abraxis BioScience Inc.'s injectable pain management drug Naropin....

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Recent Articles By Jocelyn

February 22, 2019
Tracing Puerto Rico's Journey Through Bankruptcy
November 09, 2016
After Trump's Triumph, What's Next?
January 21, 2011
United, Merck Hit With Navy Communications IP Suits
January 19, 2011
FDA Unveils Changes To Medical Device Review Process
January 19, 2011
8th Circ. Revives Class Action Over KV Recalls
January 18, 2011
Weil Advises Advent In $1.5B Buy Of Priory From RBS
January 13, 2011
Ex-Home Diagnostics CEO Charged With Insider Trading
January 04, 2011
FDA Tackles Food Safety As Funding Remains Uncertain
December 16, 2010
Elan, Eisai To Pay $214M Over Zonegran Marketing
December 15, 2010
FDA Warns Of Hidden Ingredients In Supplements

Navinta Infringed Abraxis' Naropin Patents: Judge

Documents

Related Sections

Recent Articles By Jocelyn